Internal workforce, symbolism and licensed products: 17th Asian Games

Learning outcomes The questions raised in the case study could escort a classroom or online discussion for understanding licensed product consumption motives among the internal workforce. Case overview/synopsis Despite the Asiad (an abbreviation of Asian Games) being organized in the most populous continent, its financial profitability is minimal compared with the summer Olympic Games and other major sporting events. Thereby, Asiad board members are seeking to understand how they can target the right segment via licensed products. This will ultimately increase licensed product sales. On July 1, 2017, a board meeting was held in which the licensing product manager, Young Lee, proposed to target the internal workforce via licensed products based on 17th Asiad’s data and previous literature. Lee analyzed the attributes of licensed products sold at 17th Asiad and its psychological connection with the internal workforce. Hence, the purpose of this case study was to decipher the internal workforce feasibility as the right segment to target via licensed products for Asiad's management. The case study’s primary data was collected via IB worldwide (now Galaxia SM CO, Ltd), one of the leading sport marketing organizations in South Korea. The IB worldwide (now Galaxia SM CO, Ltd) signed an exclusive product license agreement with the Incheon Asian Games Organizing Committee jointly and individually with the Olympic Council of Asia to produce licensed products (e.g. Mascot dolls). This realistic case study should be understood through the lens of symbolic interactionism. Finally, this study is important to consider because the internal workforce licensed products consumption has gained little attention in sports marketing literature. Complexity Academic Level The case can be taught in marketing research and consumer behavior courses. Subject code CSS 8: Marketing. Supplementary materials Teaching notes are available for educators only.

Analysis of Seaweed Cracker Product Marketing Strategy at the Marine and Fisheries Independent Training Center (P2MKP) Balikpapan City, East Kalimantan

Pusat Pelatihan Mandiri Kelautan dan Perikanan (P2MKP) is a seaweed cultivation business field that located in Jalan Mulawarman Gang Anyer RT.13 No. 44 Manggar, Balikpapan City, East Kalimantan. The selling method they applied has no specific strategy in marketing, the selling method they applied only provide current needs of customers.Strategy formulation starts with the input stage to formulating the strategy; identify and analyze the factors of internal and external company’s environment. The next stage is the matching stage to result a proper strategy alternative with combining the internal and external factors. The result of IFE and EFE matrix included into IE matrix to detect company location. After the location of company was detected in the IE matrix, then SWOT analysis was required to formulate strategy alternative. The last stage, decision stage, it decides which one will be the priority with using Analysis Hierarchy Process as recommended strategy for the company. It results strategy is;(1) Maintain a relationship with the government to get patent product license, (2) To create an innovation of products with using technology and occur coordination with related instances to get BPOM RI and halal certification, (3) To maintain a cooperation to get government support in widening the marketing area, (4) Increasing production or stocks volume with using technology, (5) To reach the efficient production cost with maintaining the same product price, and the sixth strategy is build the partnerships to increasing the quality of product so the customer value is achieved.

Empowering Women Ex-Migrant Workers and Domestic Violence Victims through Komunitas Perempuan Singkong Jaya

This article seeks to understand the empowerment of women ex-migrant workers who have faced various problems before, during and after going back to the homeland as ex-migrant workers. These problems include unemployment, family’s affairs, exploitation, discrimination and domestic violence. Komunitas Perempuan Singkong Jaya has been established to carry out empowerment programs to overcome these problems. The purpose of this study is to identify the needs as well as the problems that hinder the implementation of the programs and seeks to find the solutions. This study employs descriptive qualitative approach to examine the implementation of the development programs which have been conducted by Komunitas Perempuan Singkong Jaya located in Desa Sukowilangun, Kec. Kalipare, Kab. Malang. Based on the findings, there are several problems in the implementation of development programs, including the lack of capital and facilities, packaging and marketing, as well as product license problems. Addressing these problems, some intervention programs have been conducted, including training and funding which have generated intended outputs. However, this study also found that the change in lifestyle of these women ex-migrant workers has resulted in their being reluctant to be involved in the development programs.

Principles of drug use in palliative care

This chapter includes a formulary of the drugs most commonly used in the palliative care setting as well as advice surrounding common pharmacological challenges. These include drug interactions, prescribing in patients with co-morbidities, managing toxicity, the use of syringe drivers, and the impact of medications on driving. It provides a useful overview of current pharmacological practice in the UK in the context of end-of-life care and the need to consider both deprescribing as well as escalation of treatment when appropriate. By law in the UK, a medication must be given a MA (formally, a product license) by the Medicines and Healthcare Products Regulatory Agency (MHRA). The MA specifies the indication, dose, route and patient populations for which the drug can be marketed. Drugs can be used legally in clinical situations that fall outside the remit of the MA, referred to as ‘off-label’ (e.g. a different indication, dose, route, or method of administration than that specified in the MA). Off-label use of drugs in palliative care is routine, with the responsibility for prescribing under such circumstances lying with the prescriber. The prescriber must be fully informed about the actions and uses of the medicinal product and should provide information on the benefits and risks of off-license prescribing to the patient (or their proxy) to facilitate an informed decision regarding treatment options.

Better medicines for children: challenges and unmet needs

Better medicines for children: challenges and unmet needs This review deals with the use of medicinal products in children. Many medicinal products administered routinely to paediatric patients have been either not licensed for use in children (unlicensed use) or have been prescribed outside the terms of their product license (off-label prescribing). A lot of surveys have been conducted in the context of identifying the extent of off-label used drugs in children documenting high rates (45-60 %) of such use. Recognising and meeting challenges as development of suitable formulations for very young children and realization of clinical trials involving children present important steps in the enhancement of the present situation. To improve the health of children in Europe, the Regulation (EC) No 1901/2006 addressing the pharmaceutical industry, research teams and member states proposing important incentives and obligations was assigned. Paediatric Investigation Plan and Paediatric Use Marketing Authorisation present the key measures of the EU regulation on medicinal products for paediatric patients.